These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 21087629
1. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629 [Abstract] [Full Text] [Related]
2. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA. Neurology; 2011 Mar 22; 76(12):1051-8. PubMed ID: 21422457 [Abstract] [Full Text] [Related]
3. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. Skogman BH, Lager M, Henningsson AJ, Tjernberg I. Eur J Clin Microbiol Infect Dis; 2017 Nov 22; 36(11):2221-2229. PubMed ID: 28730535 [Abstract] [Full Text] [Related]
4. Borrelia antibodies in children evaluated for Lyme neuroborreliosis. Bennet R, Lindgren V, Zweygberg Wirgart B. Infection; 2008 Oct 22; 36(5):463-6. PubMed ID: 18791841 [Abstract] [Full Text] [Related]
8. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P. Scand J Infect Dis; 2013 Jul 22; 45(7):526-30. PubMed ID: 23521134 [Abstract] [Full Text] [Related]
9. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Barstad B, Tveitnes D, Dalen I, Noraas S, Ask IS, Bosse FJ, Øymar K. Infect Dis (Lond); 2019 Jul 22; 51(11-12):856-863. PubMed ID: 31573360 [Abstract] [Full Text] [Related]
10. Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms. Tveitnes D, Øymar K, Natås O. Scand J Infect Dis; 2009 Jul 22; 41(5):355-62. PubMed ID: 19253089 [Abstract] [Full Text] [Related]
12. CXCL13 chemokine in pediatric and adult neuroborreliosis. Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E. Acta Neurol Scand; 2011 Nov 22; 124(5):321-8. PubMed ID: 21320077 [Abstract] [Full Text] [Related]
14. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Markowicz M, Schötta AM, Kundi M, Bogovič P, Ogrinc K, Strle F, Stanek G. Ticks Tick Borne Dis; 2018 Jul 22; 9(5):1137-1142. PubMed ID: 29705691 [Abstract] [Full Text] [Related]
16. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U, Mygland A. J Neurol; 2008 May 22; 255(5):732-7. PubMed ID: 18344056 [Abstract] [Full Text] [Related]
17. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid. Vermeersch P, Resseler S, Nackers E, Lagrou K. Diagn Microbiol Infect Dis; 2009 Jul 22; 64(3):347-9. PubMed ID: 19376674 [Abstract] [Full Text] [Related]
19. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Øymar K, Tveitnes D. Scand J Infect Dis; 2009 Jul 22; 41(2):88-94. PubMed ID: 19065451 [Abstract] [Full Text] [Related]